Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group.

Henderson TO, Bardwell JK, Kao PC, Nathan PC, Landier W, Mostoufi-Moab S, Brinkman TM, Schulte F, Park JR, Armenian SH, Naranjo A, Subramaniam M, Marachellian A, Diskin SJ, London WB, Diller LR

Open source

DOI: 10.1016/s2352-4642(25)00241-x
Published: 2025 Nov
Container: The Lancet. Child & adolescent health
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-25-00241-x,
  title = {Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group.},
  author = {Henderson TO and Bardwell JK and Kao PC and Nathan PC and Landier W and Mostoufi-Moab S and Brinkman TM and Schulte F and Park JR and Armenian SH and Naranjo A and Subramaniam M and Marachellian A and Diskin SJ and London WB and Diller LR},
  year = {2025},
  journal = {The Lancet. Child \& adolescent health},
  doi = {10.1016/s2352-4642(25)00241-x},
  url = {https://doi.org/10.1016/s2352-4642(25)00241-x}
}

RIS

TY  - JOUR
TI  - Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group.
AU  - Henderson TO
AU  - Bardwell JK
AU  - Kao PC
AU  - Nathan PC
AU  - Landier W
AU  - Mostoufi-Moab S
AU  - Brinkman TM
AU  - Schulte F
AU  - Park JR
AU  - Armenian SH
AU  - Naranjo A
AU  - Subramaniam M
AU  - Marachellian A
AU  - Diskin SJ
AU  - London WB
AU  - Diller LR
PY  - 2025
JO  - The Lancet. Child & adolescent health
DO  - 10.1016/s2352-4642(25)00241-x
UR  - https://doi.org/10.1016/s2352-4642(25)00241-x
ER  -

APA

TO, H., JK, B., PC, K., PC, N., W, L., S, M., TM, B., F, S., JR, P., SH, A., A, N., M, S., A, M., SJ, D., WB, L., & LR, D. (2025). Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group.. The Lancet. Child & adolescent health. https://doi.org/10.1016/s2352-4642(25)00241-x

Source records

pubmed · retrieved 2026-09-26T10:18:08.805Z